AI
ByteDance spinoff Anew Labs raises $290M for AI drug discovery at $1.5B valuation
Anew Labs completes $290M fundraising round
1 Sep 16 2:30 AM · 11d ago · 1 article · 1 post · 2 sources · development 1 of 1
Shanghai-based Anew Labs, a ByteDance spinoff focused on AI-powered drug discovery, raised $290 million from investors including HSG and IDG Capital at a $1.5 billion valuation.
“Sources: Shanghai-based Anew Labs, a ByteDance spinoff using AI for drug discovery, raised $290M from HSG, IDG Capital, and others at a $1.5B valuation”
Reuters · techmeme ↗Anew Labs ByteDance spinoff, AI drug discovery startupByteDance Parent companyHSG Lead investorIDG Capital Co-investor
The whole story articlesposts the bright band is this development · numbered dots are the others · click one to jump
Sep 17Sep 18Sep 19Sep 20Sep 21Sep 22Sep 23Sep 24Sep 25yesterdaynow · 10:23 PM ET
What was reported 1 claim about this development
-
first by WOWTALE, 11d ago · also Reuters, SCMP
All 1 developments of ByteDance spinoff Anew Labs raises $290M for AI drug… →
NewswiresMastodonGoogle News